Tariq Arshad - 11 Jul 2022 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
SVP/Chief Medical Officer
Signature
/s/ Tariq Arshad
Issuer symbol
QLGN
Transactions as of
11 Jul 2022
Net transactions value
$0
Form type
4
Filing time
04 Aug 2022, 16:16:42 UTC
Previous filing
10 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QLGN Stock Option (Right to Buy) Award $0 +102,000 $0.000000 102,000 11 Jul 2022 Common Stock 102,000 $0.5136 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the stock option vest over three years in equal annual installments from the date of grant.

Remarks:

Exhibit 24 - Power of Attorney